Cell MedX (OTCMKTS:CMXC) Shares Up 213.7% – Here’s What Happened

Cell MedX Corp. (OTCMKTS:CMXC) rose 213.7% on Monday . The stock traded as high as $0.16 and last traded at $0.16. Approximately 100 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 20,342 shares. The stock had previously closed at $0.05.

Cell MedX Stock Performance

The stock has a 50 day moving average of $0.20 and a 200-day moving average of $0.09.

About Cell MedX

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.